Ex vivo activation of the GCN2 pathway metabolically reprograms T cells leading to enhanced adoptive cell therapy
Ontology highlight
ABSTRACT: Ex vivo activation of the GCN2 pathway metabolically reprograms T cells leading to enhanced adoptive cell therapy
PROVIDER: PRJNA1074242 | ENA |
REPOSITORIES: ENA
ACCESS DATA